Replimune Group, Inc. - REPL

Insiders (Form 4) · last 180 days · showing up to 200 transactions · Form 144 is shown in the SEC filings tab
Visible: 0
Transaction codes: P = Open-market purchase · S = Open-market sale · A = Grant/award · M = Exercise/conversion of derivative · G = Gift · F = Tax withholding · J = Other · A/D: A = Acquired (buy/receive) · D = Disposed (sell/give)
Filed Owner Title Code A/D Shares Price Value Shares after SEC
Apr 06, 2026 Chief Commercial Officer S D 6,500.0 8.01 52,065.0 151,588.0 View
Feb 20, 2026 G D 25,000.0 0.0 0.0 1,380,071.0 View
Dec 19, 2025 Chief Accounting Officer A A 10,000.0 0.0 0.0 78,284.0 View
Dec 19, 2025 Chief Executive Officer A A 200,000.0 0.0 0.0 533,576.0 View
Dec 19, 2025 Chief Financial Officer A A 60,000.0 0.0 0.0 194,368.0 View
Dec 19, 2025 Chief Commercial Officer A A 35,000.0 0.0 0.0 158,088.0 View
Dec 19, 2025 Chief Medical Officer A A 60,000.0 0.0 0.0 199,685.0 View
Dec 11, 2025 M D 3,169.0 0.0 0.0 0.0 View
Dec 11, 2025 S D 3,169.0 10.4 32,957.6 0.0 View
Dec 11, 2025 M A 3,169.0 1.75 5,545.75 3,169.0 View
Dec 04, 2025 Chief Executive Officer S D 10,000.0 11.13 111,300.0 333,576.0 View
Nov 19, 2025 Chief Medical Officer S D 7,248.0 9.1 65,956.8 139,685.0 View
Nov 19, 2025 Chief Commercial Officer S D 5,208.0 9.1 47,392.8 123,088.0 View